 REHOVOT, Israel and WILMINGTON, Del. and MONMOUTH JUNCTION, N.J., Jan. 19, 2023 GLOBE NEWSWIRE Advaxis, Inc. OTCQX: ADXS, a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered Listeria monocytogenes Lm, today announced the completion of a previously announced merger with Ayala Pharmaceuticals, Inc. Nasdaq: ... The post Advaxis and Ayala Pharmaceuticals Complete Merger appeared first on ForexTV... 